Clinical Trials in Spinal and Bulbar Muscular Atrophy—Past, Present, and Future

Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy

(2015) Kentaro Sahashi et al.   HUMAN MOLECULAR GENETICS

A functional scale for spinal and bulbar muscular atrophy: Cross-sectional and longitudinal study

(2015) Atsushi Hashizume et al.   NEUROMUSCULAR DISORDERS

210th ENMC International Workshop: Research and clinical management of patients with spinal and bulbar muscular atrophy, 27–29 March, 2015, Naarden, The Netherlands

(2015) Maria Pennuto et al.   NEUROMUSCULAR DISORDERS

Huntington disease

(2015) Gillian P. Bates et al.   Nature Reviews Disease Primers

Correlation of clinical and molecular features in spinal bulbar muscular atrophy

(2014) P. Fratta et al.   NEUROLOGY

New Routes to Therapy for Spinal and Bulbar Muscular Atrophy

(2013) Anna Rocchi et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature

(2013) A. Chiò et al.   NEUROEPIDEMIOLOGY

Pilot trial of clenbuterol in spinal and bulbar muscular atrophy

(2013) G. Querin et al.   NEUROLOGY

Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study

(2013) Tracey A. Willis et al.   PLoS One

Developing treatment for spinal and bulbar muscular atrophy

(2012) Kenneth H. Fischbeck   PROGRESS IN NEUROBIOLOGY

Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA)

(2012) Masahisa Katsuno et al.   PROGRESS IN NEUROBIOLOGY

Molecular Pathophysiology and Disease-Modifying Therapies for Spinal and Bulbar Muscular Atrophy

(2011) Haruhiko Banno   ARCHIVES OF NEUROLOGY

Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial

(2011) Lindsay E Fernández-Rhodes et al.   LANCET NEUROLOGY

Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial

(2010) Masahisa Katsuno et al.   LANCET NEUROLOGY

Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy

(2009) Haruhiko Banno et al.   ANNALS OF NEUROLOGY

Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease)

(2009) N. Preisler et al.   NEUROLOGY

IGF-1: Elixir for Motor Neuron Diseases

(2009) Theodora Papanikolaou et al.   NEURON

Overexpression of IGF-1 in Muscle Attenuates Disease in a Mouse Model of Spinal and Bulbar Muscular Atrophy

(2009) Isabella Palazzolo et al.   NEURON

Role of β-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease

(2008) Gordon S. Lynch et al.   PHYSIOLOGICAL REVIEWS